We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
John Alexander

John H Alexander MD, MHS, FACC, FAHA, FESC

Professor of Medicine in Cardiology, Duke Clinical Research Institute, Duke University School of Medicine, Duke Health, Durham, North Carolina

John H. Alexander, MD, MHS, is a cardiologist and Professor of Medicine in the Department of Medicine, Division of Cardiology at Duke University School of Medicine and the Vice Chief for Clinical Research in the Division of Cardiology. He is the Director of Cardiovascular Research at the Duke Clinical Research Institute where he oversees a broad portfolio of cardiovascular clinical trials and observational clinical research programs and mentors a large group of clinical research faculty and fellows. He is a member of the American Society of Clinical Investigation.

Dr. Alexander’s clinical interests are in acute and chronic cardiovascular disease, valvular heart disease, and echocardiography. His research is focused the conduct of clinical trials, specifically on the therapeutics of acute coronary syndromes, chronic coronary artery disease, atrial fibrillation, and cardiac surgery.

Dr. Alexander has published extensively and has served as the principle investigator of numerous multicenter clinical trials. He currently serves as the co-chair of the Clinical Trial Transformation Initiative (CTTI).

Disclosures

Dr. Alexander discloses the following:

Research support from Boehringer Ingelheim, Bristol Myers Squibb, CryoLife, CSL Behring, Food and Drug Administration, National Institutes of Health, VoluMetrix, and XaTek.
Consulting/Honoraria from AbbVie, Bayer, Bristol Myers Squibb, Novo Nordisk, Pfizer, Portola, Quantum Genomics, XaTek, and Zafgen.